Recent Securities Litigations

CareDx Inc. Common Stock (NASDAQ: CDNA)

26 Days left to seek lead plaintiff status.

Company Name:CareDx Inc. Common Stock
Stock Symbol:NASDAQ: CDNA
Class Period Start:02/24/2021
Class Period End (inclusive):05/05/2022
Filing Deadline:07/22/2022

The Class Action alleges that, during the Class Period, Defendants misled investors and/or failed to disclose that: (1) Defendants had engaged in a variety of improper and illegal schemes to inflate testing services revenue and demand, including pushing a surveillance protocol through inaccurate marketing materials, offering extravagant inducements or kickbacks to physicians and other providers, and improperly bundling expensive testing services with other blood tests as part of the RemoTraC service; (2) these practices, and others, subjected CareDx to an undisclosed risk of regulatory scrutiny; (3) these practices rendered the Company’s testing services revenue reported throughout the Class Period artificially inflated; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

CareDx Inc. Common Stock (NASDAQ: CDNA) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.